<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5828">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03031080</url>
  </required_header>
  <id_info>
    <org_study_id>5396</org_study_id>
    <nct_id>NCT03031080</nct_id>
  </id_info>
  <brief_title>BOND Study: the Benefit Of Night Splinting in Dupuytrens'</brief_title>
  <acronym>BOND</acronym>
  <official_title>The Effectiveness of Night Splinting After Collagenase Injection for Dupuytren's Contracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Liverpool and Broadgreen University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royal Liverpool and Broadgreen University Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BOND study is a prospective, randomised single blinded controlled trial to assess the
      effect of night splinting in patients who have had collagenase injection and manipulation
      therapy for Dupuytren's Contracture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial will assess the effectiveness of night splinting in Dupuytrens' contracture on
      functional and quality of life outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised Controlled Trial - Block Randomisation</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Investigator, Outcomes Assessor</masking>
    <masking_description>Initial heath-care provider and participant are not masked as would be impossible to do so. Outcome assessor (a different health care provider) and investigators will be masked as to whether the patient is in the splinted or unsplinted cohort.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>At 0 weeks, 12 weeks and 52 weeks</time_frame>
    <description>To assess change in range of motion measured in degrees between pre-treatment, immediately post-treatment, 12 weeks post-treatment and 12 months post-treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PEM Questionnaire</measure>
    <time_frame>At 0 weeks, 12 weeks and 52 weeks</time_frame>
    <description>Patient Evaluation Measure to give disability score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>URAM Questionnaire</measure>
    <time_frame>At 0 weeks, 12 weeks and 52 weeks</time_frame>
    <description>Hand specific outcome questionnaire to assess quality of life outcomes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Dupuytren Contracture</condition>
  <arm_group>
    <arm_group_label>Splinted</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be given Thermoplastic Hand Splint to wear overnight for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Un-Splinted</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will not wear a night splint</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermoplastic Hand Splint</intervention_name>
    <description>Thermoplastic Night splint created and moulded to the individual patients hand in-house using generic thermoplastic.</description>
    <arm_group_label>Splinted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Single digit contractures greater than 30 degrees

          2. No prior surgery for their contractures.

          3. Successful collagenase and manipulation therapy (contracture reduced to within 10
             degrees of full extension).

        Exclusion Criteria:

          1. Multiple digit contractures

          2. Prior surgery for their contractures.

          3. Failure of collagenase and manipulation therapy (contracture not reduced to within 10
             degrees of full extension).

          4. Inability to consent to treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graham Cheung, MBBCh FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant Hand Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Brown, MBBCh, FRCS</last_name>
    <phone>01517062000</phone>
    <phone_ext>3697</phone_ext>
    <email>daniel.brown@rlbuht.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>RD&amp;I Governance Manager</last_name>
    <phone>01517062000</phone>
    <phone_ext>3320</phone_ext>
    <email>RGT@rlbuht.nhs.uk</email>
  </overall_contact_backup>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 23, 2017</lastchanged_date>
  <firstreceived_date>January 23, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Collagenase, Night-splinting, Dupuytrens, Contracture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
